Pulmonary haemorrhage refers to bleeding into the air spaces of the lung. It can be massive and sudden or develop gradually. If not detected and treated at the right time, it can cause severe health hazards. Numerous conditions, such as autoimmune diseases, infections, heart problems, coagulation issues, and toxic exposures, can cause pulmonary haemorrhage.
People of all ages can be affected, though children and those with specific underlying conditions are more likely to experience it. Identification of the classic triad can raise suspicion for pulmonary haemorrhage; however, many patients do not exhibit all three features, and diagnosis relies on clinical evaluation, imaging, laboratory findings, and often bronchoscopy. Keep reading to understand the triad of symptoms of pulmonary haemorrhage.
Pulmonary Haemorrhage refers to bleeding that originates from the lungs' vasculature into the airways or air sacs (alveoli). It is a serious syndrome that can be acute and life-threatening or, in rarer cases, chronic. It most commonly occurs when the delicate capillaries surrounding the lung's air sacs (alveoli) are damaged, allowing blood to fill the alveolar spaces. Bleeding can also originate from larger vessels or lesions in the bronchi.
The onset of Pulmonary Haemorrhage can be sudden and severe, constituting a life-threatening medical emergency. In some instances, it may present with milder, recurrent episodes, but any pulmonary bleeding requires immediate medical evaluation due to its potential severity.
The classic diagnostic triad associated with pulmonary haemorrhage includes the following features:
Although it may not be present in approximately one-third of adult cases and up to half of paediatric cases, this is the most identifiable sign.
Anaemia due to blood loss, reflected by reduced haemoglobin or haematocrit levels; iron deficiency may develop in chronic or recurrent cases.
Diffuse or patchy infiltrates, which indicate blood accumulation within the lung tissue, are visible on chest X-rays or CT (computed tomography) scans.
Other symptoms may include the following:
The presentation can be insidious or sudden, and massive haemorrhage may lead to rapid cardiorespiratory compromise.
Pulmonary haemorrhage occurs due to several conditions. Here are some of them:
Autoimmune disorders like systemic vasculitides (e.g., Goodpasture syndrome, systemic lupus erythematosus) cause inflammation and damage to lung blood vessels, which can lead to pulmonary haemorrhage.
Mitral stenosis, which increases pressure in the lung circulation and predisposes it to bleed, is another reason for pulmonary haemorrhage.
Coagulation diseases or anticoagulant medications can lead to impaired blood clotting, increasing the risk of pulmonary haemorrhage.
Bacterial, viral, or fungal infections (e.g., tuberculosis, leptospirosis) can damage lung tissue directly, leading to pulmonary haemorrhage.
Inhalation of certain chemicals, drugs (e.g., cocaine, some medications), or vaping-related lung injury can increase the risk of pulmonary haemorrhage.
Both hematopoietic stem cell and solid organ transplants can increase the risk of haemorrhage.
Sometimes, no specific cause is found, especially in children (idiopathic pulmonary hemosiderosis). However, identifying the underlying cause is critical for guiding treatment and preventing recurrence.
Complications of pulmonary haemorrhage can be life-threatening and severe, highlighting the critical nature of this medical condition. The following are the primary complications associated with pulmonary haemorrhage:
Here are some of the diagnostic methods that help detect pulmonary haemorrhage:
Assessing risk factors, underlying diseases, and symptoms such as haemoptysis, anaemia, and respiratory distress can help detect haemorrhage.
Chest X-ray and CT scans are essential to detect pulmonary infiltrates. CT may show ground-glass opacities or areas of consolidation, indicating blood in the alveoli.
Complete blood count to assess anaemia, coagulation profile, and inflammation or autoimmune disease markers can determine whether you have a pulmonary haemorrhage.
Depending on the suspected cause, tests for autoimmune markers, infectious agents, or toxic exposures may be performed.
The treatment procedures for pulmonary haemorrhage include the following:
Bronchoscopy is used to confirm pulmonary haemorrhage, assess severity, exclude infection, and localize bleeding. In selected cases of focal endobronchial bleeding, topical vasoconstrictive agents may be used, but this is not standard therapy for diffuse alveolar haemorrhage.
Embolization is a minimally invasive procedure in which a doctor inserts a thin catheter into a blood vessel, usually through the groin, and guides it to the bleeding area in the lungs. Special materials like coils or plugs are then released through the catheter to block the targeted vessel, effectively stopping the bleeding and preventing further blood loss.
Doctors prescribe antibiotics for infections (e.g., penicillin for leptospirosis). If autoimmune disorders cause haemorrhage, immunosuppressive therapy, such as corticosteroids, cyclophosphamide, etc., is provided.
Correcting coagulation disorders by reversing anticoagulation or treating underlying bleeding disorders can also help manage pulmonary haemorrhage.
Surgery is performed only if less invasive treatments like bronchoscopy and embolization fail to control lung bleeding. In such cases, removing the tumour or lesion responsible for the bleeding may be necessary to resolve the problem.
The cure of pulmonary haemorrhage depends on the severity of the condition, the underlying cause, and the timing of treatment. Patients can often recover completely if the underlying cause (such as an infection, autoimmune disease, or drug reaction) is found and treated quickly.
For instance, prompt antibiotic treatment can result in complete recovery if the pulmonary haemorrhage is caused by severe leptospirosis (Weil's disease). However, the prognosis may be less favourable and supportive care or long-term management may be required if the bleeding is severe, frequent, or linked to chronic conditions.
Early detection and effective treatment of pulmonary haemorrhage are essential to reduce death rates and avert chronic problems. Knowing the signs and symptoms of pulmonary haemorrhage will help individuals appropriately manage the condition.
Also Read:
→ What is Stage 4 IgA Nephropathy